- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
TEXT ME Study Reveals How Apps Can Help Manage Cardiovascular Disease
TEXT ME, a study using text messages to improve management of cardiovascular disease, offered examples of how mobile applications can be used to manage health conditions.
TEXT ME, a study using text messages to improve management of cardiovascular disease, offered examples of how mobile applications can be used to manage health conditions.
According to Med City News:
An editorial citing the study noted that the process for clinical validation could use some improvement and offered some recommendations.
For those unfamiliar with it, the TEXT ME randomized clinical trial (short for Tobacco, Exercise and Diet Messages) sent text messages with advice, motivation and information on diet, physical activity and smoking cessation to roughly half of the 710 participants with cardiovascular disease over a six-month period. The rest did not receive them. It then compared LDL levels, blood pressure and other relevant data. Those who received the text messages showed statistically significant, albeit modest, improvement compared with those who did not.
Drs. Zubin Eapen and Eric Peterson of Duke Clinical Research Institute, who wrote the editorial, liked the way the investigators worked with patients (as well as academics and clinicians) both in structuring the messages sent to participants. They were part of the collaboration process for developing the messages used in the study. The study also tracked patients’ use of text messages and satisfaction with them. Their insights could easily apply to the broader clinical validation programs underway at companies and institutions.
Click here to read the full article on Med City News.
Â
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â